According to a recent LinkedIn post from Artera, the company is featured in a session at the ViVE 2026 conference alongside customer Hanger, Inc. The session is framed around the progression from general interest in artificial intelligence to the deployment of AI agents in patient access workflows.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that Hanger’s VP of Patient & Employee Experience, Carrie Davis, will discuss how Hanger is developing AI strategies and collaborating with Artera to transform care experiences. For investors, this suggests Artera is positioning itself as a partner for operational AI deployment in healthcare, which may support its credibility and pipeline among health systems.
Participation on a ViVE stage with a recognizable healthcare provider brand could enhance Artera’s visibility within a key buyer audience. This type of exposure may aid business development efforts, potentially contributing to future revenue growth if demonstrations of successful AI agent deployment lead to additional commercial agreements.
The focus on “AI race” and patient access indicates Artera is targeting a segment where payers and providers seek cost savings and efficiency gains. If the collaboration with Hanger yields measurable improvements in patient experience or operational metrics, it could strengthen Artera’s competitive position in the health tech and AI-enabled patient engagement market.